LEGISLATIVE UPDATE

Monday, May 13

Drug Pricing: Finance Committee Chairman Chuck Grassley (R-IA) and Senator Dick Durbin (D-IL) Introduce Bipartisan Legislation to Codify HHS Rule Requiring Disclosure of Prescription Drug Pr Brought Against 20 Generic Drug Manufacturers for Prescription Drug Price-Fixing

Senate Budget Committee Ranking Member Bernie Sanders (I-VT) and House Committee on Oversight and Reform Chairman Elijah Cummings (D-MD) Pledge to Hold Drug Companies Accountable for Price-Fixing icing in Consumer Advertising  

  • Energy and Commerce Chairman Frank Pallone, Jr. (D-NJ) Statement Following Anti-Trust Lawsuit

Tuesday, May 14

Behavioral Health: Senator James Inhofe (R-OK) Introduces S. 1464 to Provide Grants to State, Local, Territorial and Tribal Law Enforcement Agencies to Obtain Behavioral Health Response Training for Law Enforcement Officers   

Drug Pricing: House Ways and Means Health Subcommittee Chairman Lloyd Doggett (D-TX) Announces Hearing Entitled, “Protecting Patients From Surprise Medical Bills” on Tuesday, May 21, 2019, at 2:00 pm in Room 1100 of the Longworth House Office Building

Wednesday, May 15

Drug Pricing: Senate Finance Committee Ranking Member Ron Wyden (D-OR) Introduces Legislation to Improve Health Care Price Transparency  

  • House Passes First Legislation Aimed at Lowering Drug Prices

Thursday, May 16

Drug Pricing: House Committee on Oversight and Reform Holds Hearing Entitled “HIV Prevention Drug: Billions in Corporate Profits after Millions in Taxpayer Investment,” Examining Gilead’s Pricing of Truvada for Pre-Exposure Prophylaxis

  • Energy and Commerce Chairman Frank Pallone, Jr. (D-NJ) Delivers Statement on Consideration of H.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act

REGULATORY UPDATE

Monday, May 13

HRSA: HRSA Awards $24 million to Rural Organizations for Rural Communities Opioid Response Program Planning Grants

Tuesday, May 14

HHS: Health and Human Services Assistant Secretary for Health and Senior Advisor to the Secretary for Opioid Policy Brett P. Giroir, M.D. Announces Creation of Interdepartmental Substance Use Disorders Committee  

Wednesday, May 15

HHS: Office of the Assistant Secretary for the U.S. Department of Health and Human Services Announces Request for Nominations of Individuals Interested in Being Considered for Appointment to Interdepartmental Substance Use Disorders Committee   

Thursday, May 16

FDA: FDA Approves First Anticoagulant for Pediatric Patients to Treat Pulmonary Embolisms, Deep Vein Thrombosis, and Other Life-Threatening Blood Clots

Friday, May 17

NIH: Project to Prevent Opioid Tampering Wins Top Addiction Science Award at 2019 Intel International Science and Engineering Fair (ISEF)

  • Statement by Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, and Maureen M. Goodenow, Ph.D., NIH Associate Director for AIDS Research and Director, Office of AIDS Research Accouncing HIV Vaccine Awareness day May 18, 2019
  • New Clinical Research Shows Integrated Stepped Alcohol Treatment for People in HIV Care Improves both HIV and Alcohol-Related Outcomes

UPCOMING EVENTS

NIH
Meeting: National Advisory Council on Aging
May 21, 2019 3:00 PM – 5:00 PM
National Institutes of Health, Building 60, Lecture Hall, One Cloister Court, Bethesda, MD 20892

Health
Protecting Patients from Surprise Medical Bills
May 21, 2019 – 2:00 pm
1100 Longworth House Office Building

Healthcare
Key Design Components and Considerations for Establishing a Single-Payer Health Care System
Wed, 05/22/2019 – 10:00am
210 Cannon House Office Building

Drug Pricing
Hearing: Improving Drug Pricing Transparency and Lowering Prices for American Consumers
May 21, 2019 10:30 am
John D. Dingell Room, 2123 Rayburn House Office Building

HASC and HVAC
Hearing: Military and Veteran Suicide: Understanding the Problem and Preparing for the Future
May 21, 2019 2:00 pm
B234 Longworth House Office Building  

NIH
Meeting: National Advisory Mental Health Council
May 30, 2019 9:00 AM – 1:00 PM
National Institutes of Health, Neuroscience Center Building (NSC), Conference Rooms C/D/E, 6001 Executive Boulevard, Rockville, MD 20852

NIH
Meeting: National Heart, Lung, and Blood Advisory Council
June 4, 2019 8:00 AM – 12:00 PM
National Institutes of Health, Porter Neuroscience Research Center, Building 35A Convent Drive, Bethesda, MD 20892

HRSA
Meeting: Council on Graduate Medical Education
June 5, 2019  8:30 AM – 5:00 PM & June 6 8:30 AM – 2:00 PM
5600 Fishers Lane, Rockville, Maryland 20857

NIH
National Advisory Council on Aging
September 10-11, 2019 3:00 PM – 5:00 PM
National Institutes of Health, Neuroscience Center Building (NSC), North Bethesda, 6001 Executive Boulevard, Rockville, MD 28052

NIH
Meeting: Center for Scientific Review
September 23, 2019 8:30 AM – 3:00 PM
National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892

NIH
Meeting: Board of Scientific Counselors, NIDDK
October 10-11, 2019 8:00 AM – 6:00 PM
National Institutes of Health, Building 10, Solarium Conference Room 9S233, 10 Center Drive, Bethesda, MD 20892

NIH
Meeting: Board of Scientific Counselors, National Institute of Neurological Disorders and Stroke
June 23-25, 2019 6:00 PM – 12:00 PM
Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814

CMS
Meeting: Medicare Advisory Panel on Clinical Diagnostic Laboratory Tests
June 24, 2019 8:00 AM – 4:30 PM
Main auditorium of the Centers for Medicare & Medicaid Services (CMS), Central Building, 7500 Security Boulevard, Baltimore, Maryland 21244-1850